Literature DB >> 17900704

Pharmacological analysis of excitatory and inhibitory synaptic transmission in horizontal brainstem slices preserving three subnuclei of spinal trigeminal nucleus.

Sang-Mi Han1, Dong-Kuk Ahn, Dong-Ho Youn.   

Abstract

Spinal trigeminal nucleus (Vsp) consists of three subnuclei: oralis (Vo), interpolaris (Vi) and caudalis (Vc). Previous anatomical studies using antero-/retro-grade tracers have suggested that intersubnuclear ascending/descending synaptic transmissions exist between subnuclei. However, pharmacological properties of the intersubnuclear synaptic transmission have not been studied yet. Since three subnuclei are located in Vsp along rostro-caudal axis, it will be necessary to prepare horizontal brainstem slices to perform pharmacological analysis of the intersubnuclear synaptic transmission. We here show horizontal brainstem slices retaining three subnuclei, and that, using blind whole-cell recordings in the slices, synaptic transmission may be abundantly retained between subnuclei in the horizontal slices, except for the transmission from Vo to Vc. Finally, pharmacological analysis shows that excitatory and inhibitory synaptic responses, respectively, are mediated by AMPA and NMDA receptors and by GABA(A) and glycine receptors, with a differential contribution to the synaptic responses between subnuclei. We therefore conclude that horizontal brainstem slices will be a useful preparation for studies on intersubnuclear synaptic transmission, modulation and plasticity between subnuclei, as well as, further, other brainstem nuclei.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900704     DOI: 10.1016/j.jneumeth.2007.08.011

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  5-HT(1B) receptors inhibit glutamate release from primary afferent terminals in rat medullary dorsal horn neurons.

Authors:  I-S Choi; J-H Cho; C-H An; J-K Jung; Y-K Hur; J-K Choi; I-S Jang
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons.

Authors:  Tally M Largent-Milnes; Deborah M Hegarty; Sue A Aicher; Michael C Andresen
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

3.  Trigeminal brainstem modulation of persistent orbicularis oculi muscle activity in a rat model of dry eye.

Authors:  Mostafeezur Rahman; Kazunari Shiozaki; Keiichiro Okamoto; Randall Thompson; David A Bereiter
Journal:  Neuroscience       Date:  2017-03-11       Impact factor: 3.590

4.  Large conductance calcium-activated potassium channels: their expression and modulation of glutamate release from nerve terminals isolated from rat trigeminal caudal nucleus and cerebral cortex.

Authors:  Irene Samengo; Diego Currò; Vincenzo Barrese; Maurizio Taglialatela; Maria Martire
Journal:  Neurochem Res       Date:  2014-03-26       Impact factor: 3.996

5.  P2X7 receptors exert a permissive effect on the activation of presynaptic AMPA receptors in rat trigeminal caudal nucleus glutamatergic nerve terminals.

Authors:  Diego Currò; Pierluigi Navarra; Irene Samengo; Maria Martire
Journal:  J Headache Pain       Date:  2020-07-02       Impact factor: 7.277

Review 6.  Mechanisms of Peripheral and Central Pain Sensitization: Focus on Ocular Pain.

Authors:  Giulia Puja; Balazs Sonkodi; Rita Bardoni
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

7.  Signal transduction mechanisms underlying group I mGluR-mediated increase in frequency and amplitude of spontaneous EPSCs in the spinal trigeminal subnucleus oralis of the rat.

Authors:  Ji-Hyeon Song; Eun-Sung Park; Sang-Mi Han; Seung-Ro Han; Dong-Kuk Ahn; Dong-Ho Youn
Journal:  Mol Pain       Date:  2009-09-02       Impact factor: 3.395

8.  Morphology and connections of intratrigeminal cells and axons in the macaque monkey.

Authors:  Susan Warren; Paul J May
Journal:  Front Neuroanat       Date:  2013-05-29       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.